Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.3.14 (
ATP synthase
)
7,042
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
EGCG
(Epigallocatechin-3-gallate) has an allelopathic inhibitory effect on Microcystis aeruginosa. Cellular structure, physiological and biochemical reactions and gene expression were examined to explore the mechanism of inhibition. As was shown in electron microscopy, the structure of the cell wall, cell membrane and thylakoid was disrupted by
EGCG
.
EGCG
also reduced the efficiency of photosynthesis and the electron transfer rate in M. aeruginosa cells, as was determined with a flow cytometer. Quantitative real-time PCR analysis demonstrated that gene expression of the core proteins of the photosynthesis centers PSI and PSII and
ATP synthase
were reduced, while the expression of the phycobilisome degradation protein A gene (nbl A) was elevated. The expression of the universal stress protein gene increased, which would enhance the adaptive capacity of Microcystis cells to polyphenols and oxidative stress. Furthermore,
EGCG
elevated the level of reactive oxygen species (ROS) in M. aeruginosa cells, and thus caused oxidative cellular damage. When treated with
EGCG
at low concentrations (10 and 40 mg L(-)(1)), the cells were able to activate defense systems to degrade the excess ROS. But at a concentration of 70 mg L(-)(1), oxidative stress exceeded tolerance limits, and the cells were severely damaged. We concluded that damage to photosynthesis and oxidative stress were the primary mechanisms for the allelopathic effect of
EGCG
on M. aeruginosa.
...
PMID:Changes in the physiology and gene expression of Microcystis aeruginosa under EGCG stress. 2501 28